Kenetik Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series 1
- Latest Deal Amount
-
$10.7M
- Investors
-
1
Kenetik General Information
Description
Producer of a ketone energy drink intended for a healthy boost of energy and focus to support peak performance, on the field, at home, at work, or in life. The company's products are made using plant-based ingredients through a sustainable bio-fermentation process that are sugar-free and have no caffeine, enabling customers to continue their lifestyle and stay healthy.
Contact Information
Website
www.drinkkenetik.comCorporate Office
- 3916 Vero Road
- Suite F
- Halethorpe, MD 21227
- United States
Corporate Office
- 3916 Vero Road
- Suite F
- Halethorpe, MD 21227
- United States
Kenetik Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 25-Feb-2026 | $10.7M | Completed | Generating Revenue | ||
| 1. Seed Round | Completed | Generating Revenue |
Kenetik Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Series 1 | ||||||||
| Seed Series 4 | ||||||||
| Seed Series 3 | 18,714,712 | $0.000100 | $0.06 | $0.06 | 1x | $0.06 | 10.01% | |
| Seed Series 2 | 1,342,281 | $0.000100 | $0.08 | $0.08 | 1x | $0.08 | 0.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Kenetik Patents
Kenetik Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3223325-A1 | Methods to produce therapeutic formulations comprising hydroxybutirate and hydroxyvalerate, therapeutic formulations and uses thereof | Pending | 28-Jun-2021 | ||
| EP-4363599-A1 | Methods to produce therapeutic formulations comprising hydroxybutirate and hydroxyvalerate, therapeutic formulations and uses thereof | Pending | 28-Jun-2021 | ||
| US-20240368644-A1 | Methods to produce therapeutic formulations comprising hydroxybutirate and hydroxyvalerate, therapeutic formulations and uses thereof | Pending | 28-Jun-2021 | ||
| WO-2023278240-A1 | Methods to produce therapeutic formulations comprising hydroxybutirate and hydroxyvalerate, therapeutic formulations and uses thereof | Inactive | 28-Jun-2021 | ||
| CA-3170624-A1 | Composition of (d)-.beta.-hydroxybutyric acid, (d)-.beta.-hydroxyvalericacid, and (d)-1,3 butanediol as a nutritional supplement and therapeuticagent | Pending | 05-Mar-2020 | A23L33/10 |
Kenetik Signals
Kenetik Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Quench Ventures | Venture Capital | Minority |
Kenetik FAQs
-
When was Kenetik founded?
Kenetik was founded in 2018.
-
Where is Kenetik headquartered?
Kenetik is headquartered in Halethorpe, MD.
-
What is the size of Kenetik?
Kenetik has 8 total employees.
-
What industry is Kenetik in?
Kenetik’s primary industry is Beverages.
-
Is Kenetik a private or public company?
Kenetik is a Private company.
-
What is Kenetik’s current revenue?
The current revenue for Kenetik is .
-
How much funding has Kenetik raised over time?
Kenetik has raised $12.3M.
-
Who are Kenetik’s investors?
Quench Ventures has invested in Kenetik.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process